Blog Archives

US HEALTH CARE SYSTEM BEGINS TO EMBRACE COST EFFECTIVENESS AS A CENTRAL COMPONENT OF “VALUE”

ViH Cover 2016_07-08

Value in Health Series Indicates We May Have Reached a Tipping Point  Princeton, NJ—August 29, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a series of articles suggesting that the application of cost-effectiveness analysis

Tagged with: , , , , , , , , ,
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health

EFFECT OF ADOPTING NEW CHOLESTEROL GUIDELINES IN ISRAEL

Tel Aviv, Israel – Statins for lowering LDL cholesterol levels (“bad cholesterol,”) are the most commonly prescribed medications in the Western world. The guidelines of the American College of Cardiology (ACC) and the American Heart Association (AHA) for statin therapy

Tagged with: , , ,
Posted in Uncategorized

SHOULD COST-EFFECTIVENESS BE INCLUDED IN CLINICAL TREATMENT GUIDELINES?

At ISPOR’s Annual International Meeting, speakers addressed cost-effectiveness issues at both societal and patient levels Princeton, NJ, USA, May 19, 2015 – Oncology and cardiology professional organizations have embraced consideration of cost-effectiveness and the value of treatments in developing their

Tagged with: , , , , ,
Posted in Announcements, ISPOR News & Press

ISPOR CELEBRATES 20 YEARS OF GROWTH AND ACHIEVEMENT AT 2015 ANNUAL INTERNATIONAL MEETING

Princeton, NJ, USA, April 29, 2015 – The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will hold its 20th Annual International Meeting, May 16-20, 2015 in Philadelphia, PA, USA. The 2015 Annual International Meeting marks ISPOR’s 20th anniversary and

Tagged with: , , , , , ,
Posted in Announcements, ISPOR News & Press
Categories
Follow ISPOR
RSS FeedFriend me on FacebookFollow my company on LinkedInFollow me on TwitterWatch me on YouTube